Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12795337 | 0.73 | MAPK1 (0.36) | MEN1KMT2AHSD17B10LMNA | |
| SCHEMBL14434940 | 0.66 | KMT2A (0.48) | MEN1KMT2AHSD17B10LMNA | |
| SCHEMBL14373813 | 0.66 | MAPT (0.45) | MEN1KMT2AGPR3GAAESR1 | |
| SCHEMBL10216422 | 0.65 | GPR3 (0.54) | MEN1KMT2AGPR3ESR1ESR2 | |
| SCHEMBL12521442 | 0.62 | ERN1 (0.47) | MEN1KMT2AUSP2 | |
| SCHEMBL10101672 | 0.62 | — | — | |
| SCHEMBL3837964 | 0.61 | APP (0.52) | MEN1KMT2AHSD17B10 | |
| SCHEMBL13646677 | 0.61 | KMT2A (0.34) | MEN1KMT2AGAALMNA | |
| SCHEMBL22650231 | 0.58 | GPR3 (0.54) | MEN1KMT2AGPR3ESR1ESR2 | |
| SCHEMBL31533451 | 0.58 | HTR2B (0.47) | MEN1KMT2AGAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7896931-B2 | Hair dye composition | KAO CORPORATION (JP) | 2011-03-01 | — | — | US | disclosed |
| US-7896931-B2 | Hair dye composition | KAO CORPORATION (JP) | 2011-03-01 | — | — | US | disclosed |
| US-20100146716-A1 | HAIR DYE COMPOSITION | KAO CORPORATION (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100146716-A1 | HAIR DYE COMPOSITION | KAO CORPORATION (JP) | 2010-06-17 | — | — | US | disclosed |
| WO-2009005139-A2 | HAIR DYE COMPOSITION | KAO CORPORATION (JP) | 2009-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100146716-A1 | HAIR DYE COMPOSITION | ARSA, H1-4, H1-0 | MEN1 2614/4885KMT2A 493/4885GPR3 1551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.